Clinical trial · Interventional
The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy
Randomized, Self Controlled Study on the Effect of Oral Supplement of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy
NCT02771756CI-TRIAL-00022153unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to research more reasonable and safe methods of nutritional support to improve the nutritional status of tumor patients, which guarantees the anti-tumor treatment such as chemotherapy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| chemotherapy | Radiation | — | UNRESOLVED |
| nutrition education | Other | — | UNRESOLVED |
| zhen qishen capsule and Oral Supplement of Yuyikang | Dietary Supplement | — | UNRESOLVED |
| zhen qishen capsule placebo and Oral Supplement of Yuyikang placebo | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- test group
- description
- Zhen qishen capsule (2 capsules, Bid) and Oral Supplement of Yuyikang (50g, Bid), a total of 150 people, are used for 42 days continuously.
- interventionNames
- Dietary Supplement: zhen qishen capsule and Oral Supplement of Yuyikang
- Radiation: chemotherapy
- Other: nutrition education
- type
- PLACEBO_COMPARATOR
- label
- placebo group
- description
- Zhen qishen capsule placebo (2 capsules, Bid) and Oral Supplement of Yuyikang placebo (50g,Bid), a total of 150 people, are used for 42 days continuously.
- interventionNames
- Dietary Supplement: zhen qishen capsule placebo and Oral Supplement of Yuyikang placebo
- Radiation: chemotherapy
- Other: nutrition education
Primary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged between 18 and 70 years old * Breast or lung cancer was diagnosed by pathology or cytology * ECOG score: 0-2 points * PG-SGA: 2-8 points, while the weight loss within 3 months less than 5% * The organ function is good, with chemotherapy index. ANC is equal to or over 1.5 \* 10\^9/L, PLT is equal to or over 100\* 10\^9/L, HGB is equal to or over 90g/L * Bilirubin is equal to or less than 1.5 times of the normal upper limit, AP, AST, ALT is less than or equal to 2 times of normal upper limit * Ccr is equal to or over 50mL/min * Life expectancy is equal to or over 12 weeks Exclusion Criteria: * Complete or incomplete intestinal obstruction * A severe infection or difficult to control diabetes * History of organ transplantation, or current use of immunosuppressive agents * An intervention in nutritional supplements, or a metabolic disorder * Parenteral nutrition must be applied * Alcoholism or drug addiction * Pregnancy or lactation, or women of childbearing age refuse contraception * There are potential factors that interfere with the mental, psychological, family, social or geographical and other factors of the research project * There are other diseases that may interfere with the results of this study, such as the second primary tumor * For any other reason, the researchers were unable to complete the study
References
Publications (0)
Data not yet available
No reference posted for this study.